| Stem definition | Drug id | CAS RN |
|---|---|---|
| antiasthmatics or antiallergics, not acting primarily as antihistaminics anti-allergic or anti-inflammatory, not acting as anti-histaminics | 2074 | 69372-19-6 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 24, 1999 | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D018494 | Histamine Agents |
| MeSH PA | D006633 | Histamine Antagonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
| FDA PE | N0000175628 | Decreased Histamine Release |
| FDA EPC | N0000175630 | Mast Cell Stabilizer |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Allergic rhinitis | indication | 61582004 | |
| Asthma | indication | 195967001 | DOID:2841 |
| Allergic conjunctivitis | indication | 473460002 | DOID:11204 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.26 | acidic |
| pKa2 | 3.56 | Basic |
None
None
None
| ID | Source |
|---|---|
| 4021298 | VUID |
| N0000148735 | NUI |
| D01088 | KEGG_DRUG |
| 100299-08-9 | SECONDARY_CAS_RN |
| 4021210 | VANDF |
| 4021211 | VANDF |
| 4021298 | VANDF |
| 4021299 | VANDF |
| C0053881 | UMLSCUI |
| CHEBI:134936 | CHEBI |
| CHEMBL1201198 | ChEMBL_ID |
| DB00885 | DRUGBANK_ID |
| CHEMBL1201050 | ChEMBL_ID |
| 57697 | PUBCHEM_CID |
| C055139 | MESH_SUPPLEMENTAL_RECORD_UI |
| 7329 | IUPHAR_LIGAND_ID |
| 6449 | INN_ID |
| 2C09NV773M | UNII |
| 19551 | RXNORM |
| 31417 | MMSL |
| 8304 | MMSL |
| 008300 | NDDF |
| 008301 | NDDF |
| 116112001 | SNOMEDCT_US |
| 417508009 | SNOMEDCT_US |
| 417669009 | SNOMEDCT_US |
None